Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis

Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis

(2014) Li Zhang et al.   LABORATORY INVESTIGATION

Redefining Dermatomyositis

(2014) Yves Troyanov et al.   MEDICINE

Prognostic Factors for Myositis-Associated Interstitial Lung Disease

(2014) Tomoyuki Fujisawa et al.   PLoS One

Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease

(2014) Takahisa Gono et al.   RHEUMATOLOGY

Pulmonary Manifestations of Polymyositis/Dermatomyositis

(2014) Robert Hallowell et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis

(2014) Moises Labrador-Horrillo et al.   Journal of Immunology Research

Genome-Wide Association Study of Dermatomyositis Reveals Genetic Overlap With Other Autoimmune Disorders

(2013) Frederick W. Miller et al.   ARTHRITIS AND RHEUMATISM

Diagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease

(2013) Rekha Vij et al.   CHEST

Administration of cathepsin B inhibitor CA-074Me reduces inflammation and apoptosis in polymyositis

(2013) Yurong Feng et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

An approach to the development of interstitial lung disease in dermatomyositis: A study of 230 cases in China

(2013) Hao Wu et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

The prognostic value of HRCT in myositis-associated interstitial lung disease

(2013) Kiminobu Tanizawa et al.   RESPIRATORY MEDICINE

Skin ulcer is a predictive and prognostic factor of acute or subacute interstitial lung disease in dermatomyositis

(2013) Kazuyoshi Ishigaki et al.   RHEUMATOLOGY INTERNATIONAL

Utility of Anti-Melanoma Differentiation-Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta-Analysis

(2013) Zhiyong Chen et al.   ARTHRITIS CARE & RESEARCH

Anti-Melanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum

(2013) John C. Hall et al.   ARTHRITIS CARE & RESEARCH

Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome

(2012) I. Marie et al.   AUTOIMMUNITY REVIEWS

Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

(2012) Yoshinao Muro et al.   CLINICAL RHEUMATOLOGY

Interstitial lung disease in connective tissue disorders

(2012) Aryeh Fischer et al.   LANCET

The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM

(2012) T. Koga et al.   RHEUMATOLOGY

Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort

(2012) F. Chua et al.   RHEUMATOLOGY

Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients

(2012) Yuechi Sun et al.   RHEUMATOLOGY INTERNATIONAL

Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment

(2012) Tsuneyo Mimori et al.   Current Rheumatology Reports

Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study

(2011) H Chinoy et al.   ANNALS OF THE RHEUMATIC DISEASES

Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients

(2011) I. Marie et al.   ARTHRITIS AND RHEUMATISM

KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis

(2011) M. Fathi et al.   JOURNAL OF INTERNAL MEDICINE

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis

(2010) Eun Ha Kang et al.   BMC MUSCULOSKELETAL DISORDERS

Interstitial Lung Disease Associated With the Idiopathic Inflammatory Myopathies

(2010) Geoffrey R. Connors et al.   CHEST

Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis

(2010) Kei Hoshino et al.   RHEUMATOLOGY

Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease

(2009) Thomas J. Richards et al.   ARTHRITIS AND RHEUMATISM

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

(2009) Shinji Sato et al.   ARTHRITIS AND RHEUMATISM

Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis

(2009) Hiroshi Mukae et al.   CHEST

Interstitial lung disease in polymyositis and dermatomyositis

(2009) I-Jung Chen et al.   CLINICAL RHEUMATOLOGY

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

(2009) Ran Nakashima et al.   RHEUMATOLOGY

The inflammatory milieu in idiopathic inflammatory myositis

(2009) Ann M. Reed et al.   Current Rheumatology Reports

Interstitial lung disease in polymyositis and dermatomyositis: Longitudinal evaluation by pulmonary function and radiology

(2008) Maryam Fathi et al.   ARTHRITIS AND RHEUMATISM